Sidney Kimmel Comprehensive Cancer Center
@KimmelCancerCtr
Followers
11K
Following
7K
Media
3K
Statuses
8K
The NCI-designated Sidney Kimmel Comprehensive Cancer Center at Jefferson is working to eradicate cancer across Greater Philadelphia & beyond.
Philadelphia, PA
Joined May 2009
Sidney Kimmel Comprehensive Cancer Center researchers have uncovered novel mechanisms by which TOMM20 drives cancer aggressiveness in fibrosarcoma and chondrosarcoma. Read more: #SarcomaAwarenessMonth.
jeffersonhealth.org
New research from the Sidney Kimmel Comprehensive Cancer Center – Jefferson Health has uncovered novel mechanisms by which the translocase of outer mitochondrial membrane receptor 20 (TOMM20) drives...
0
0
0
RT @CD_AACR: From the July issue: Cytosolic Phospholipase A2 Determines Intercellular Heterogeneity of Stress Granules and Chemotherapy Res….
0
6
0
RT @JEFFsurgery: Congratulations to Dr. @AlliricWillis on his induction into the prestigious American Surgical Association - the nation's o….
0
4
0
RT @JEFFsurgery: On June 26, the @KimmelCancerCenter mobile van visited the @CityOfChesterPA to share gun safety education & free gun locks….
0
3
0
RT @JEFFsurgery: Thanks to a $84,000 grant from Accelerate Health Equity @ahephl, our Jefferson Center for Injury Research & Prevention is….
0
2
0
RT @Cancers_MDPI: 📢New #SpecialIssue “Cancer #Immunotherapy-Related Adverse Events and Therapy-Related Accelerated Aging” edited by Dr. Gra….
0
1
0
RT @APDicker: Dr. Lydia Komarnicky has had a tremendous impact on patients, families, faculty, and trainees. We thank her for her selflessn….
0
1
0
Congratulations, @CharlesJYeoMD!.
Dr. @CharlesJYeoMD is serving as 2025-26 Vice President of the American Surgical Association. Read more:
0
0
2
The next session, which will offer tips on how to manage hot flashes, mood changes, trouble sleeping, and other symptoms of early menopause due to breast cancer treatment, is on Thursday, June 19.
Join us for The Survivorship Series, presented in partnership with @LivingBeyondBC. This free program offers tips, tools, and real talk on topics to help you feel confident! @KimmelCancerCtr
0
0
0
Join us tomorrow for the virtual B Informed Liver Cancer Patient Conference, which we are co-hosting with the Hepatitis B Foundation. Register here: #hepatitisB #livercancer
0
0
1
Thank you to @subaruphilly for the generous donation of more than $26,000 that will support groundbreaking cancer research and bring hope to patients. For the 2nd year, Ciocca selected us as a hometown charity partner during the annual Subaru Share the Love Event. 💙
0
0
4
RT @JeffHealthNE: Our first Community Cancer Screening & Education Day at Jefferson Frankford Hospital was a success!. Attendees received v….
0
1
0
El Dr. Carlos Pérez de Jefferson se unirá al programa de radio @philatinos el miércoles 11 de junio de 9 a 10 a.m. para compartir lo que debe saber sobre el cáncer de próstata. Escuche en el sitio web de Philatinos en o en su página de Facebook.
0
0
1
Dr. Marcia Brose reported an update on efficacy and safety of larotrectinib in patients with TRK fusion thyroid carcinoma at #ASCO25.
An updated analysis on larotrectinib for patients with TRK fusion thyroid carcinoma showed compelling data on the agent’s efficacy and safety, including a high and durable response rate and a manageable safety profile. #thycsm #ASCO25 | @KimmelCancerCtr.
0
1
3
RT @Arshi_Syal: Had an amazing time presenting my poster and attending ASCO, 25! My last one as a resident. Can’t wait to be back next year….
0
3
0
RT @DanielLinMD: Ashley Miles, MSN, OCN presenting on sepsis protocol for outpatient infusion center @TJUHospital, ensuring early managemen….
0
2
0
Dr. Marcia Brose reported long-term safety & efficacy data of larotrectinib in patients with TRK fusion thyroid carcinoma at #ASCO25:
0
0
1
#ASCO25 roundup: SKCCC researchers analyzed use of GLP-1 & GIP receptor agonists among #prostatecancer pts. ➡️
1
2
2
RT @lymphomahub: CONGRESS | #ASCO25 | POSTER.Pierluigi Porcu of @KimmelCancerCtr, shared long-term results from the phase 2 TELLAMAK study….
0
7
0
#ASCO25: Don't miss the heme malignancies oral abstract session this afternoon! Dr. Margie Kasner is leading a discussion on the future of therapy for acute myeloid leukemia and myelodysplastic syndromes.
0
0
1